Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients

Chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab (FCR) can induce long-term remissions in patients with chronic lymphocytic leukemia. Treatment efficacy with Bruton's tyrosine kinase inhibitors was found similar to FCR in untreated chronic lymphocytic leukemia patients with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bloehdorn, Johannes, Krzykalla, Julia, Holzmann, Karlheinz, Gerhardinger, Andreas, Jebaraj, Billy Michael Chelliah, Bahlo, Jasmin, Humphrey, Kathryn, Tausch, Eugen, Robrecht, Sandra, Mertens, Daniel, Schneider, Christof, Fischer, Kirsten, Hallek, Michael, Döhner, Hartmut, Benner, Axel, Stilgenbauer, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883563/
https://www.ncbi.nlm.nih.gov/pubmed/33730841
http://dx.doi.org/10.3324/haematol.2020.251561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883563/
https://www.ncbi.nlm.nih.gov/pubmed/33730841
http://dx.doi.org/10.3324/haematol.2020.251561

Ejemplares similares